This article is more than 5 years old. Information may no longer be current.

AMO and Carl Zeiss reach patent agreement

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

SANTA ANA, Calif. — Advanced Medical Optics has entered into a U.S. patent license agreement with Carl Zeiss Meditec regarding the use of femtosecond laser technology, according to an AMO press release.

Within the scope of the agreement, AMO's IntraLase subsidiary has granted a non-exclusive, royalty-bearing license to Carl Zeiss for it to use the IntraLase patent portfolio to provide femtosecond laser technology for corneal surgery.

Other terms of the agreement are confidential, the release said.

In November 2006, before being acquired by AMO, IntraLase Corp. had filed a lawsuit against Carl Zeiss alleging that Carl Zeiss improperly used confidential product information to develop a device based on the IntraLase FS femtosecond laser.